Entospletinib Plus Intensive Induction/Consolidation Chemotherapy in Newly Diagnosed NPM1-mutated AML
Clinical trial NCT05020665 · TERMINATED
Trial details
- NCT number
- NCT05020665
- Sponsor
- Kronos Bio
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-24
- Primary completion
- 2023-03-30
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.